Heidi Lindner is a senior partner and head of the Patent Litigation Department of Arochi & Lindner, with over 35 years experience in the area. She is considered a leading patent litigator in life sciences subjects and has a consistent record of wins, including several landmark cases, for clients in the pharmaceuticals, biotech and medical devices industries.
Chambers and Partners’ Latin American Guide ranks Heidi in it Top Tier in IP and also ranks her in Life Sciences. Chambers 2019 edition reports that clients describe her as “a great lawyer who is definitely one of the leaders.” World Trademark Review 1000 portrays her work as “impeccable”: “She knows the market better than anyone and is a tough negotiator and a dynamic, commercially minded litigator.”
In addition to litigation, Heidi practice includes licensing. She also advises on regulatory issues affecting the life sciences sector in Mexico and serves as Counsel to the Mexican Association of Generic Drug Companies. She has advised different Senate Commissions during the legislative discussions on amendments to IP provisions and, lately, to the new IP law.
Most recently, she has been a member of the elite private sector team representing the pharmaceutical industry, which advised the Mexican Government in the Intellectual Property Chapter during the negotiations of the Trans-Pacific Partnership (TPP) and the Free Trade Agreement Mexico-USA-Canada (USMCA/TMEC).
Member of AIPPI, ASIPI, AMPPI, INTA and the Mexican Bar Association. She is a former president of AMPPI (Mexican Intellectual Property Association) from 1998 to 2001, being the only woman with this position. The Mexico chapter of the International Association for the Protection of International Property (AIPPI).